» Articles » PMID: 18229562

Risk Factors of Hospitalization and Readmission of Patients with COPD Exacerbation--systematic Review

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2008 Jan 31
PMID 18229562
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive lung disease (COPD) exacerbations are a significant cause of morbidity and mortality. Data regarding factors which causes or prevents exacerbations is very limited. The aim of this systematic review is to summarize the results from available studies to identify potential risk factors for hospital admission and/or re-admission among patients experiencing COPD exacerbations.

Methods: We undertook a systematic review of the literature. Potential studies were identified by searching the electronic databases: PubMed, EMBASE, BIOSIS, CINAHL, PsycINFO, Cochrane library, reference lists in trial reports, and other relevant articles.

Results: Seventeen articles that met the predefined inclusioncriteria were identified. Heterogeneity of study designs, risk factors and outcomes restrict the result to only a systematic review and precluded a formal meta-analysis. In this review, three predictive factors: previous hospital admission, dyspnea and oral corticosteroids were all found to be significant risk factors of readmissions and variables including using long term oxygen therapy, having low health status or poor health related quality of life and not having routine physical activity were all associated with an increased risk of both admission and readmission to hospital.

Conclusions: There are a number of potential modifiable factors that are independently associated with a higher risk of COPD exacerbation requiring admission/readmission to the hospital. Identifying these factors and the development of targeted interventions could potentially reduce the number and severity of such exacerbations.

Citing Articles

Influenza Vaccination in Adults in the United States with COPD before and after the COVID-19 Pandemic (2017-2022): A Multi-Year Cross-Sectional Study.

Wold M, Oancea S Vaccines (Basel). 2024; 12(8).

PMID: 39204054 PMC: 11359522. DOI: 10.3390/vaccines12080931.


Internet of Things-Based Home Respiratory Muscle Training for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.

Chen Q, Wu X, Huang Y, Chen L Int J Chron Obstruct Pulmon Dis. 2024; 19:1093-1103.

PMID: 38800522 PMC: 11128236. DOI: 10.2147/COPD.S454804.


Developing and validating prediction models for severe exacerbations and readmissions in patients hospitalised for COPD exacerbation (SERCO) in China: a prospective observational study.

Wang Y, He R, Ren X, Huang K, Lei J, Niu H BMJ Open Respir Res. 2024; 11(1).

PMID: 38719500 PMC: 11086534. DOI: 10.1136/bmjresp-2023-001881.


Associations between outpatient care and later hospital admissions for patients with chronic obstructive pulmonary disease - a registry study from Norway.

Moger T, Holte J, Amundsen O, Haavaag S, Edvardsen A, Bragstad L BMC Health Serv Res. 2024; 24(1):500.

PMID: 38649963 PMC: 11036724. DOI: 10.1186/s12913-024-10975-4.


The predictive value of baseline symptom score and the peripheral CD4CD8 double-positive T cells in patients with AECOPD.

He S, Wu S, Chen T, Huang W, Yu A, Cao C BMC Pulm Med. 2023; 23(1):478.

PMID: 38031059 PMC: 10685522. DOI: 10.1186/s12890-023-02751-7.


References
1.
Connolly M, Lowe D, Anstey K, Hosker H, Pearson M, Roberts C . Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related factors and service organisation. Thorax. 2006; 61(10):843-8. PMC: 2104767. DOI: 10.1136/thx.2005.054924. View

2.
Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

3.
Ringbaek T, Viskum K, Lange P . Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?. Eur Respir J. 2002; 20(1):38-42. DOI: 10.1183/09031936.02.00284202. View

4.
Moher D, Cook D, Eastwood S, Olkin I, Rennie D, Stroup D . Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999; 354(9193):1896-900. DOI: 10.1016/s0140-6736(99)04149-5. View

5.
Pouw E, ten Velde G, Croonen B, Kester A, Schols A, Wouters E . Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr. 2000; 19(2):95-9. DOI: 10.1054/clnu.1999.0074. View